DelveInsight has launched a new report on “Chronic Venous Insufficiency – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Chronic Venous Insufficiency – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Chronic Venous Insufficiency, historical and forecasted epidemiology as well as the Chronic Venous Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Chronic Venous Insufficiency Market Report:
- As per the study conducted by Owayed Al Shammeri et al. (2014), Chronic Venous Insufficiency (CVI) commonly affects lower limbs with a prevalence ranging between 25–40% and 10–20% in women and men, respectively. The annual incidence is 2–6% in women and 1.9% in men.
- As per the study conducted by Owayed Al Shammeri et al. (2014),. Among all chronic venous insufficiency patients, approximately 1% to 2.7% will develop a venous stasis ulcer. The formation of an ulcer carries a poor prognosis, with 40% of patients developing recurrence despite standard treatment. Management of chronic venous insufficiency accounts for approximately 2% of the United States’ total healthcare.
Key benefits of the report:
- Chronic Venous Insufficiency market report covers a descriptive overview and comprehensive insight of the Chronic Venous Insufficiency Epidemiology and Chronic Venous Insufficiency market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Chronic Venous Insufficiency market report provides insights on the current and emerging therapies.
- Chronic Venous Insufficiency market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Chronic Venous Insufficiency market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Chronic Venous Insufficiency market.
Chronic Venous Insufficiency Overview
Chronic venous insufficiency (CVI) typically refers to lower extremity oedema, skin trophic changes, and discomfort secondary to venous hypertension. Chronic venous insufficiency pathophysiology is either due to reflux (backward flow) or obstruction of venous blood flow. Chronic venous insufficiency can develop from the protracted valvular incompetence of superficial veins, deep veins, or perforating veins that connect them. In all cases, the result is venous hypertension of the lower extremities.
Chronic Venous Insufficiency Market
The dynamics of the Chronic Venous Insufficiency market is anticipated to change in the coming years owing to the expected launch of emerging therapies such as Verigraft, SerenaGroup, and others during the forecasted period 2018-2030.
Chronic Venous Insufficiency Pipeline Therapies and Key Companies
- P-TEV: Verigraft
- TR 987: SerenaGroup.
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Chronic Venous Insufficiency Patient Share (%) Overview at a Glance
5. Chronic Venous Insufficiency Market Overview at a Glance
6. Chronic Venous Insufficiency Disease Background and Overview
7. Chronic Venous Insufficiency Epidemiology and Patient Population
8. Country-Specific Patient Population of Chronic Venous Insufficiency
9. Chronic Venous Insufficiency Current Treatment and Medical Practices
10. Unmet Needs
11. Chronic Venous Insufficiency Emerging Therapies
12. Chronic Venous Insufficiency Market Outlook
13. Country-Wise Chronic Venous Insufficiency Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Chronic Venous Insufficiency Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Chronic Venous Insufficiency Pipeline
“Chronic Venous Insufficiency Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Chronic Venous Insufficiency market. A detailed picture of the Chronic Venous Insufficiency pipeline landscape is provided, which includes the disease overview and Chronic Venous Insufficiency treatment guidelines.
Chronic Venous Insufficiency Epidemiology
DelveInsight’s ‘Chronic Venous Insufficiency Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Chronic Venous Insufficiency epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/